Compound Detail
CHEMBL499067
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL499067 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FIHNNYNOPNUKJK-UHFFFAOYSA-N |
4
Targets
8
Activities
1
Assay Types
0
PK Parameters
11
Publications
0
Known Names
Molecular Properties
368.4
MW (Da)
4.55
ALogP
4
HBA
4
HBD
95.4
PSA (Ų)
0.37
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 8 meas. best 5.26
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| A-431 CHEMBL614069 | IC50 | 5.26 | 4.94 | 5500.0 | 3 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 4.6 | 4.6 | 24900.0 | 2 |
| Gallus gallus CHEMBL613109 | IC50 | 4.3 | 4.3 | 50600.0 | 1 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | IC50 | 4.11 | 4.11 | 77400.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| A-431 | IC50 | = | 5500.0 | nM | 5.26 | Cytotoxicity against human A431 cells | 18467105 |
| A-431 | IC50 | = | 5500.0 | nM | 5.26 | Cytotoxicity against human A431 cells | 20403693 |
| Vascular endothelial growth factor receptor 2 | IC50 | = | 24900.0 | nM | 4.6 | Inhibition of VEGFR2 expressed in human tumor cells | 18467105 |
| Vascular endothelial growth factor receptor 2 | IC50 | = | 24900.0 | nM | 4.6 | Inhibition of VEGFR2 | 20403693 |
| Gallus gallus | IC50 | = | 50600.0 | nM | 4.3 | Antiangiogenic activity against fertile leghorn chicken eggs by CAM assay | 18467105 |
| A-431 | IC50 | = | 50600.0 | nM | 4.3 | Antiangiogenic activity against human A431 cells | 20403693 |
| Platelet-derived growth factor receptor beta | IC50 | = | 77400.0 | nM | 4.11 | Inhibition of PDGFRbeta expressed in human tumor cells | 18467105 |
| Platelet-derived growth factor receptor beta | IC50 | = | 77400.0 | nM | 4.11 | Inhibition of PDGFRbeta | 20403693 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20403693 | 10.1016/j.bmcl.2010.03.064 | A-431 | 2 |
| 18467105 | 10.1016/j.bmc.2008.04.019 | Epidermal growth factor receptor | 1 |
| 18467105 | 10.1016/j.bmc.2008.04.019 | Vascular endothelial growth factor receptor 1 | 1 |
| 18467105 | 10.1016/j.bmc.2008.04.019 | Vascular endothelial growth factor receptor 2 | 1 |
| 18467105 | 10.1016/j.bmc.2008.04.019 | Platelet-derived growth factor receptor beta | 1 |
| 18467105 | 10.1016/j.bmc.2008.04.019 | A-431 | 1 |
| 18467105 | 10.1016/j.bmc.2008.04.019 | Gallus gallus | 1 |
| 20403693 | 10.1016/j.bmcl.2010.03.064 | Epidermal growth factor receptor | 1 |
| 20403693 | 10.1016/j.bmcl.2010.03.064 | Vascular endothelial growth factor receptor 1 | 1 |
| 20403693 | 10.1016/j.bmcl.2010.03.064 | Vascular endothelial growth factor receptor 2 | 1 |
| 20403693 | 10.1016/j.bmcl.2010.03.064 | Platelet-derived growth factor receptor beta | 1 |
Data from ChEMBL 36 via Core Engine